{"a": [["Cost of diabetes\u2010related amputations in minorities", "1998"], ["Is there a place for granulocyte colony\u2010stimulating factor in non\u2010neutropenic critically ill patients?", "2004"], ["Randomized prospective controlled trial of recombinant granulocyte colony\u2010stimulating factor as adjunctive therapy for limb\u2010threatening diabetic foot infection", "2002"], ["Operating characteristics of a rank correlation test for publication bias", "1994"], ["Are granulocyte colony\u2010stimulating factors beneficial in treating diabetic foot infections? A meta\u2010analysis", "2005"], ["Review: granulocyte colony\u2010stimulating factor \u2010 role and relationships in infectious diseases", "1995"], ["Impaired leucocyte functions in diabetic patients", "1997"], ["Filgrastim in the treatment of infected diabetic foot ulcers: retrospective cost analysis of a phase II randomised clinical trial", "1999"], ["New treatments in ulcer healing and wound infection", "2000"], ["Bias in meta\u2010analysis detected by a simple, graphical test", "1997"], ["Immune dysfunction in patients with diabetes mellitus (DM)", "1999"], ["Infections in diabetes mellitus and hyperglicemia", "2007"], ["Granulocyte colony\u2010stimulating factor: its potential role in infectious disease", "1999"], ["Measuring inconsistency in meta\u2010analyses", "2003"], ["Cochrane Handbook for Systematic Reviews of Interventions Version 5.0.2 [updated September 2009]", "2009"], ["Economics of the recombinant Human Granulocyte Colony\u2010Stimulating Factors", "2012"], ["Granulocyte transfusion therapy for treatment of infections after cytotoxic chemotherapy", "2003"], ["Diagnosis and treatment of diabetic foot infections", "2004"], ["2012 Infectious Diseases Society of America clinical practice guideline for the diagnosis and treatment of diabetic foot infections", "2012"], ["International Consensus on the Diabetic Foot", "2003"], ["Foot Care for People with Diabetes:The Economic Case for Change", "2012"], ["Treatment of musculoskeletal infections of the foot in patients with diabetes", "2005"], ["Chapter 6. Searching for studies", "2009"], ["Principles and practice of antibiotic therapy of diabetic foot infections", "2000"], ["Medical treatment of diabetic foot infections", "2004"], ["A systematic review of foot ulcer in patients with Type 2 diabetes mellitus. II: treatment", "1999"], ["Amputation and mortality in new\u2010onset diabetic foot ulcers stratified by etiology", "2003"], ["Granulocyte colony\u2010stimulating factor as the expecting sword for the treatment of severe sepsis", "2003"], ["Role of granulocyte colony\u2010stimulating factor in the immune response to acute bacterial infection in the nonneutropenic host: an overview", "1994"], ["A randomized controlled trial of filgrastim for the treatment of hospitalized patients with multilobar pneumonia", "2000"], ["A series of systematic reviews to inform a decision analysis for sampling and treating infected diabetic foot ulcers", "2006"], ["Systematic review of antimicrobial treatments for diabetic foot ulcers", "2006"], ["Diabetic foot problems Inpatient management of diabetic foot problems", "March 2011"], ["Systematic reviews of wound care management: (3) antimicrobial agents for chronic wounds; (4) diabetic foot ulceration", "2000"], ["A comparison of two diabetic foot ulcer classification systems: the Wagner and the University of Texas wound classification systems", "2001"], ["Growth factors in the treatment of diabetic foot ulcers: new technologies, any promises?", "2007"], ["Enhanced neutrophil functions by recombinant human granulocyte colony\u2010stimulating factor in diabetic patients with foot infections in vitro", "2001"], ["Adjunctive granulocyte colony\u2010stimulating factor therapy for diabetic foot infections", "2004"], ["The burden of diabetic foot ulcers", "1998"], ["Review Manager (RevMan)", "2011"], ["Growth factors and treatment of diabetic foot ulcers", "2002"], ["Granulocyte colony\u2010stimulating factor and granulocyte\u2010macrophage colony\u2010stimulating factor: comparisons and potential for use in the treatment of infections in nonneutropenic patients", "1999"], ["Granulocyte\u2010colony stimulating factor improves an impaired bactericidal function in neutrophils from STZ\u2010induced diabetic rats", "1993"], ["Effect of granulocyte\u2010colony stimulating factor on generation of oxygen\u2010derived free radicals and myeloperoxidase activity in neutrophils from poorly controlled NIDDM patients", "1997"], ["Search filters", "(accessed February 2009)"], ["Pharmacotherapy of lower limb diabetic ulcers", "2000"], ["Costs of deep foot infections in patients with diabetes mellitus", "2000"], ["The disvascular foot: a system for diagnosis and treatment", "1981"]], "ex": [["Growth factors and the management of the diabetic foot", "2005"], ["Granulocyte\u2010colony\u2010stimulating factor in diabetic foot infection", "1998"], ["[Treatment of critical limb ischemia and diabetic foot disease by the use of autologous stem cells].", "2011"], ["ABC of wound healing: recent advances and emerging treatments", "2006"], ["Autologous transplantation of granulocyte colony\u2010stimulating factor\u2010mobilized peripheral blood mononuclear cells improves critical limb ischemia in diabetes", "2006"], ["Autologous transplantation of granulocyte colony\u2010stimulating factor\u2010mobilized peripheral blood mononuclear cells improves critical limb ischemia in diabetes", "2005"], ["Autologous peripheral blood mononuclear cell implantation for patients with peripheral arterial disease improves limb ischemia", "2005"], ["Prevention of limb amputation in patients with limbs ulcers by autologous peripheral blood mononuclear cell implantation", "2005"], ["X. Local care and medical treatment of ischemic trophic disorders in the diabetic patients", "2002"], ["Local care and medical treatment for ischemic diabetic ulcers", "2002"], ["Autologous G\u2010CSF mobilized peripheral blood CD34(+) cell therapy for diabetic patients with chronic non\u2010healing ulcer", "2012"]], "in": [["Randomized prospective controlled trial of recombinant granulocyte colony\u2010stimulating factor as adjunctive therapy for limb\u2010threatening diabetic foot infection", "2001"], ["Randomised placebo\u2010controlled trial of granulocyte\u2010colony stimulating factor in diabetic foot infection", "1997"], ["Evaluation of granulocyte\u2010colony stimulating factor (Filgastrim) in infected diabetic foot ulcers", "2003"], ["Beneficial role of granulocyte colony stimulating factor in foot infection in diabetic patients", "2003"], ["Effects of granulocyte\u2010colony stimulating factor in the treatment of diabetic foot infection", "2001"]]}